{"name":"Curevo Inc","slug":"curevo-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQcWJPM1VBVUtZMklibGJ0UXMxZmJUU2EtTXF5c3BqV2NNTlF2VTY3aEcwTG9INi00QUJHaTlTbUNZTU1Fd0FubjFzTXk5VnpFYjF3QXZkZWw5a0xGdUZUNXZnYjdDb0hRZlphbE1sbXBENTF5S2tkQVBLUFc2M3c3R3FUY1BQWnlSUi03N1R5cmtaOEpMd0hFRUo3UmhCeG56YVdWZDR2VXdEN29ZeWw1SERRMjYtZV8xM3hvUjBCTzZCbkZ3UkJhUVp5ZDVmYnlWbnVzTUlkLWh0cmtGVHU1VlJLY1h0WWVXcUpTc0RpcDR3OTZNbm53blpfQm9Nems?oc=5","date":"2026-04-07","type":"pipeline","source":"Barchart.com","summary":"Herpes Zoster Treatment Market Size in the 7MM is projected to increase at a significantly CAGR by 2036, estimates DelveInsight - Barchart.com","headline":"Herpes Zoster Treatment Market Size in the 7MM is projected to increase at a significantly CAGR by 2036, estimates Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxNdEhFMFY5N252aFR6MG1vbG9qQW56TlBsTkI0Q2FsWVowa2pkTVNIY0hYbXlSWGdKZGVHbmF2MWhncUdFUjROUHF4REE0TjUtSTVWVzlVS01VWjRDYW96RVFwX19EVk1mRlhSdk9hVXVMWV80YzRaekpuTDBXVDVkTjE2V1VzZFRvVHF5OEdmSUoyaktSM2Via1pGbW9YTjh1b2pxd3kxc2tlS2FaN1E2bHpxSnloaUdZWjRjckZ1VDlMWFg3dnp0eG9YUEt5REtoN0JPdVh2ZkZkaXdfbjVBNEdndFBzZ1c2TUJIMU1FNUlvUkd3UFB6ODcxX2NIMUxiQm9PaXB1Umtic0c0MHJVeW8ydFFhYlN4dWNKLUtNVTZtTi1mam5ZeDBYbVZqbUYxUVZieVlueU9GNzg?oc=5","date":"2026-03-09","type":"pipeline","source":"GlobeNewswire","summary":"Herpes Zoster Market Poised for Robust Growth During the - GlobeNewswire","headline":"Herpes Zoster Market Poised for Robust Growth During the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1PNE1sYl9GenBHdnpQVmV4TnlQSGh3Y3lQNkRVQVJ6TzRqckFrV0lSeEx2UnNoYVBJY3NLNmJkMkNkeHdWOUlDLTRIWnNGZDN4Q1Z4aUM2M08zQQ?oc=5","date":"2025-04-02","type":"pipeline","source":"The Pharma Letter","summary":"Curevo Vaccine - The Pharma Letter","headline":"Curevo Vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOX1NKNzFoU0xVLVFsQW1vQWVzWmJjWkoxT0VlRzlIZHdoZnRkWGFkUDBnLXZubTU4NGVtRFgtZTlGZloxbE1vSld3RmdtbTAtOUk0S29aYi1uRmp5YU1FeTgtcHhibHFVSkNpQXhvaGdQcEJRTFNBVTVNcHFkam5ZOUM0bVlTT2E4R0lLeVkwZkswUEJoOVlqNlItNEZHd1FOUE9waUxhV0hYa0JCazY4VFNJQ1B4M2JQYlpV?oc=5","date":"2025-03-18","type":"pipeline","source":"Pharmaceutical Technology","summary":"Curevo procures $110m and former-GSK exec for shingles vaccine candidate - Pharmaceutical Technology","headline":"Curevo procures $110m and former-GSK exec for shingles vaccine candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQOWlEX3pxQ3NQRWZ2bURtWmNvTFJhX2pWa09YTk9VR2RXY0hFNnNFcTJOUjk5ZEU0dFJCdTBVeElSR21JTlU4M205R2NTTUcyb2RnN2FxQVh2ZS1RcHF6bUFwWDV0N1VoTmZ6NllNSlI1LTBtcGFrRng0XzdLQjJrMHdUY0RvSVpCZko4V3g0UVJ2SFQzOHlEazFzeTdORGdReExnOGctMUdNNmdFdW1VWlp2SnpKSHJaNmVHckl3TUMxYkJRV1hSRHlBMnJva1B3ay1ZTw?oc=5","date":"2025-03-17","type":"pipeline","source":"GlobeNewswire","summary":"Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine - GlobeNewswire","headline":"Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQaXg3anRuN3hSUkhHalF1QlVWQ2FiRng2QWM1dkxJVzg1cklvVFpla0tpdWNWd3A3bUt3dnc0NVJhVkpKeDVzY1V0OUJldmxBNVQtZ2xMN3pUb2E5dmJoS25kZ1BzQlBENjlqYlZXMktNOURJYUpkS29XYk5zekpCejh0bzhLTzRDRE1Oa0d0dWFud3BJZ0xmWG9uN1RZUDd1ZDlMSTh2S3BYaTBYbkNnaWJB?oc=5","date":"2025-03-17","type":"pipeline","source":"Fierce Biotech","summary":"Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead board - Fierce Biotech","headline":"Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPVUZza1psM0lodDRtUkd0eVhZdXRqVjBzUElQQjJ2NUxlOFN4RXR3Y0xsSkJqS0dIWE1uRGY3QjloUWZGVFFEcFFSNTZMRVgwV3RNTkJYbjhmWUxvWEVzWEV3RHp6cVZFOFliQUdKbGNyRVRfY0RaZ2c4NGhibGNyWFlFaw?oc=5","date":"2024-03-19","type":"pipeline","source":"Pharma Voice","summary":"GSK has the U.S. shingles vaccine market cornered. A jab with fewer side effects could change that. - Pharma Voice","headline":"GSK has the U.S. shingles vaccine market cornered. A jab with fewer side effects could change that.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZmJ4MjBTVkp5Z2xqaXQ4TzgzR1VvUTVmdmdpMm1NZ19WY1loV2didktZSDRieHVFbzhEWWNBWVN3Z0pPc1c5eWxPUjh5V19HWVFsLXdiTzNVdHhTYUY0Ykdlbmg2aEZYUzlLMGJVMHdWblA4NkVoTUlPRlhVVG9pWkFiTzk1RDZWQ0NtQWEwRzh2OUdmeDBuV2NGT3pTbzF1Tlpv?oc=5","date":"2024-01-08","type":"trial","source":"Fierce Biotech","summary":"Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head - Fierce Biotech","headline":"Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNUHJSZWF2bkNTVkpGdThJQ1ViVHJVeGpZaXFvSExsZkpma1FtTDV5azJyS2E4RWp1QlFZM0tKd0t6YnZQcmctMlR4RERqV2Y0b3UyMEc3amxhSnVuaHNoaHU4MzJvZW02OHFxem5MQ2kzU3dlSHhtMjdRVndhbjd4eGllSERVTXdZTjhKQ2tTZUNkM3lHOExrSkd3bml2UW9pME1Mcks3SXhXWEtpLTcydVRvYlpvOTg1a2txbWJUaF9kY3M5UXI3RDdOaFMwSTRDV0I0cGNqeXV6QjIzaXB3UE1OUmtpM2hfYWZFeHlqX2lRSlFlYUloNmhfVTZfU25VYU1yYTRMbjYteFp5ZGs0?oc=5","date":"2022-02-10","type":"pipeline","source":"businesswire.com","summary":"Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines - businesswire.com","headline":"Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vacci","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}